
|Articles|October 11, 2007
First generic Trileptal products get FDA nod
First oxcarbazepine receives approval for seizure disorders
Advertisement
Roxane Laboratories, Glenmark Pharmaceuticals, and Sun Pharmaceuticals have all received FDA approval for their generic versions of Trileptal (oxcarbazepine). The drug is indicated for use alone or in combination with other medications for the treatment of partial seizures in adults and children four years of age and older. Oxcarbazepine will be available in three strengths: 150 mg-, 300-mg, and 600-mg tablets.
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
2
Executive Order Calls for Realignment of Childhood Vaccines
3
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
4
Heat and Older Adults: What Pharmacists Need to Know
5





























































